Location History:
- Zürich, CH (2009 - 2020)
- Zurich, CH (2013 - 2024)
Company Filing History:
8 out of 12 
5 out of 36 
3 out of 32 
Years Active: 2009-2025
Certainly! Here is the article about inventor Tea Gunde:
Title: Trailblazing Inventor: Tea Gunde's Passion for Innovation
Introduction:
In the bustling city of Zurich, Switzerland, inventor Tea Gunde has carved a path of innovation that has left a lasting impact on the world of inventions. With an unwavering commitment to excellence, Tea Gunde's groundbreaking work has inspired countless aspiring inventors to dream big and create solutions that shape a better tomorrow.
Latest Patents:
Tea Gunde, a visionary inventor, holds a remarkable 18 patents. Among her latest patents are "Antibodies targeting CD137 and methods of use thereof," which focus on isolated antibodies specifically binding human CD137. Additionally, her patent on "Stable and soluble antibodies inhibiting TNFα" showcases particularly stable and soluble antibodies designed for the diagnosis and treatment of TNF-mediated disorders.
Career Highlights:
Throughout her illustrious career, Tea Gunde has made significant contributions to various companies. She has lent her expertise to Esbatech, an Alcon Biomedical Research Unit LLC, and Numab Therapeutics Ag, where she has spearheaded groundbreaking research and development initiatives.
Collaborations:
Tea Gunde has collaborated with esteemed professionals in the field, including David M Urech and Leonardo Borras. Together, they have worked tirelessly to push the boundaries of innovation and pave the way for transformative inventions in the industry.
Conclusion:
Inventor Tea Gunde's relentless pursuit of innovation, coupled with her dedication to excellence, has solidified her reputation as a trailblazer in the world of inventions. Her work serves as a beacon of inspiration for future generations of inventors, encouraging them to think boldly and create solutions that have the power to shape a brighter future for all.